{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-041314","form_type":"8-K","ticker":"SRTS","cik":"0001494891","company_name":"Sensus Healthcare, Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.655867+00:00","generated_at":"2026-06-02T05:34:00.593117+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Sensus Healthcare Q1 revenue $10.7M (up 214% YoY); net income $2.3M vs loss of $1.9M","bullets":["Revenue $10.7M, up 214% from $3.4M; shipped 26 systems vs 10 YoY.","Net income $2.3M ($0.14 diluted EPS) vs net loss $1.9M ($0.12 loss) YoY.","Adjusted EBITDA $3.0M vs negative $2.7M YoY.","Launched 'Fair Deal Agreement' recurring revenue program; cash $14.7M, no debt.","Sold first SRT-100 Vision in Asia (Taiwan) and first veterinary unit outside U.S. (Israel)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-041314","json":"https://secwatch.observer/filing/0001213900-24-041314.json","markdown":"https://secwatch.observer/filing/0001213900-24-041314.md","text":"https://secwatch.observer/filing/0001213900-24-041314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1494891/000121390024041314/0001213900-24-041314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1494891/000121390024041314/ea0205344-8k_sensus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T05:34:00.593117+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"56140b32eef6efec1ec3dd1ae031fe0d183315fc","claim":"Sensus Healthcare, Inc. reported the three months ended March 31, 2024 results: revenue $10.7 million, net income $2.3 million, or $0.14 per diluted share, EPS $0.14 per diluted share.","evidence_excerpt":"Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold · Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1494891/000121390024041314/0001213900-24-041314-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2024"},{"label":"Revenue","value":"$10.7 million"},{"label":"Net income","value":"$2.3 million, or $0.14 per diluted share"},{"label":"EPS","value":"$0.14 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}